HIV-1 Infection in infants severely impairs the immune response induced by bacille calmette-guérin vaccine

Journal of Infectious Diseases

Volumn 199, Issue 7, 2009, Pages 982-990

  Mansoor, Nazma ^a   Scriba, Thomas J ^a   De Kock, Marwou ^a   Tameris, Michele ^a   Abel, Brian ^a   Keyser, Alana ^a   Little, Francesca ^c   Soares, Andreia ^a   Gelderbloem, Sebastian ^a   Mlenjeni, Silvia ^a   Denation, Lea ^a   Hawkridge, Anthony ^a,b   Boom, W Henry ^d   Kaplan, Gilla ^e   Hussey, Gregory D ^a   Hanekom, Willem A ^a,c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b Aeras Global Tuberculosis Vaccine Foundation   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BCG VACCINATION; BCGOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOPATHOLOGY; INFANT; INFANT DISEASE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TH1 CELL; TUBERCULOSIS; ADULT; DISEASE TRANSMISSION; FEMALE; IMMUNOLOGY; NEWBORN; PREGNANCY;

ADULT; BCG VACCINE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY;

EID: 65549110325     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/597304     Document Type: Article

References (24)

1. Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a metaanalysis and assessment of cost-effectiveness. Lancet 2006; 367:1173-80.
2. World Health Organization. BCG disease. Wkly Epidemiol Rec 2004;79: 27-38.
3. World Health Organization. The world health report-make every mother and child count. 2005. Available at: http://www.who.int/whr/ 2005/en/. Accessed 15 January 2009.
4. Zar HJ, Cotton MF, Strauss S, et al. Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial. BMJ 2007; 334:136.
5. Hesseling AC, Marais BJ, Gie RP, et al. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Vaccine 2007; 25:14-8.
6. Fallo A, Torrado L, Sánchez A, Cerqueiro C, Schargrodsky L, López EL. Delayed complications of Bacille Calmette-Guerin (BCG) vaccination in HIV-infected children [abstract WeOa0104]. Presented at the 3rd IAS Conference on HIV Pathogenesis and Treatment. Available at: http:// www.iasociety.org/Default.aspx?pageId-11&abstractId-2176496. Accessed 11 February 2009.
7. Hesseling AC, Rabie H, Marais BJ, et al. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin Infect Dis 2006; 42:548-58.
8. Soares AP, Scriba TJ, Joseph S, et al. Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J Immunol 2008; 180:3569-77.
9. Rich KC, Siegel JN, Jennings C, Rydman RJ, Landay AL. Function and phenotype of immature CD4- lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers. Clin Diagn Lab Immunol 1997; 4:358-61.
10. Kuhn L, Meddows-Taylor S, Gray G, Tiemessen C. Human immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero. Clin Infect Dis 2002; 34:267-76.
11. Van Rie A, Madhi SA, Heera JR, et al. Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers. Clin Vaccine Immunol 2006; 13:246-52.
12. Kuhn L, Kasonde P, Sinkala M, et al. Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? Clin Infect Dis 2005; 41:1654-61.
13. McNally LM, Jeena PM, Gajee K, et al. Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet 2007; 369:1440-51.
14. Hanekom WA, Hughes J, Mavinkurve M, et al. Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. J Immunol Methods 2004; 291:185-95.
15. Brown H, Prescott R. Applied mixed models in medicine. Chichester, England: Wiley, 2004.
16. Murray RA, Mansoor N, Harbacheuski R, et al. Bacillus Calmette Guerin vaccination of human newborns induces a specific, functional CD8- T cell response. J Immunol 2006; 177:5647-51.
17. World Health Organization. Safety of BCG vaccine in HIV-infected children. Wkly Epidemiol Rec 2007; 82:22. Available at: http://www .who.int/vaccine-safety/topics/bcg/immunocompromised/Dec-2006/ en/. Accessed 11 February 2009.
18. Betts MR, Nason MC, West SM, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8- T cells. Blood 2006; 107: 4781-9.
19. Darrah PA, Patel DT, De Luca PM, et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 2007; 13:843-50.
20. Beveridge NE, Price DA, Casazza JP, et al. Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4- memory T lymphocyte populations. Eur J Immunol 2007; 37:3089-100.
21. Newell ML, Brahmbhatt H, Ghys PD. Child mortality and HIV infection in Africa: a review. AIDS 2004; 18(Suppl 2):S27-34.
22. National Institutes of Health. Treating HIV-infected infants early helps them live longer. NIH News. 2007. Available at: http://www.nih.gov/ news/pr/jul2007/niaid-25.htm. Accessed 15 January 2009.
23. Doerholt K, Duong T, Tookey P, et al. Outcomes for human immunodeficiency virus-1-infected infants in the United Kingdom and Republic of Ireland in the era of effective antiretroviral therapy. Pediatr Infect Dis J 2006; 25:420-6.
24. Rabie H, Violari A, Madhi S, et al. Complications of BCG vaccination in HIV-infected and-uninfected children: evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study [abstract 600]. Presented at the 15th Conference on Retroviruses and Opportunistic Infections. Available at: http://www.i-base.info/htb/v9/htb9-5-6/ Complications.html. Accessed 11 February 2009.